At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
In Brief
A Phase 4 clinical trial evaluating Vyvanse (lisdexamphetamine) and Behavior Parent Training for Attention Deficit Hyperactivity Disorder. Completed, enrolled 53 participants across 1 site.
Detailed Summary
We hypothesize that successfully treating maternal Attention Deficit Hyperactivity Disorder (ADHD) will have a beneficial effect that extends to the child. We believe that multi-component interventions combining maternal stimulant medication, Lisdexamfetamine (LDX), and Behavioral Parent Training (BPT) will improve parenting, maternal, and child outcomes. In terms of improved parenting, we hypothesize that some mothers may respond well to LDX or BPT alone and therefore may not require multi-modal treatment, whereas others may benefit most from multi-modal treatment
Study Details
Timeline
Interventions
Active ADHD drug, Vyvanse, is administered to mother.
Mother is given 8 weeks of individual sessions of behavioral parent training